CSPC Pharmaceutical Group insiders' transactions over the last year indicate alignment with shareholders and optimism for the future. However, no insider trading occurred in the last quarter.
HBM gets health boost from drug licensing deals December 22, 2023 2142.HK 1.56 (-2.5%) The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer Key Takeaways: Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion HBM Holdin...
$恒生指數(800000.HK)$dropped 62 points or 0.4% to open at 16,311 this morning (13th).$國企指數(800100.HK)$fell 24 points or 0.4% to 5,589.$恒生科技指數(800700.HK)$slid 26 points or 0.7% to 3,703. The Central Economic Work Conference proposed to meet reasonable financing needs of real estate enterprises of different ownerships equally. Chinese developers rose this morning before dropping yesterday (12th).$龍湖集團(00960.HK)$and ...
The EPS uptick implies the share price fall could be due to previous overvaluation. Metrics besides dividends and revenue trend might better account for the price changes. Despite recent share price rise, the company has experienced major performance losses over the last five years.
CSPC Pharmaceutical's accrual ratio indicates cash conversion beneath expectations, implying potential lower actual earnings power. Despite this, its earnings per share growth over past three years is positive.
石藥集團股票討論區
December 22, 2023
2142.HK
1.56
(-2.5%)
The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer
Key Takeaways:
Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion
HBM Holdin...
The Central Economic Work Conference proposed to meet reasonable financing needs of real estate enterprises of different ownerships equally. Chinese developers rose this morning before dropping yesterday (12th). $龍湖集團(00960.HK)$ and ...
There was HKD268.3 million and HKD166.3 million Southbound Trading net outflow from $騰訊控股(00700.HK)$ and $中國海洋石油(00883.HK)$ .
For $港股通(滬)(GangGuTong.HK)$ , $石藥集團(01093.HK)$ was the most active stock with highest net inflow of HKD145.5 ...
關注我,讓大模型分析投資觸手可及。讓大模型挖掘你的投資潛力。
$阿里巴巴-SW(09988.HK)$ $蔚來-SW(09866.HK)$ $百度集團-SW(09888.HK)$ $騰訊控股(00700.HK)$ $中國石油股份(00857.HK)$ $中國聯通(00762.HK)$ $中國移動(00941.HK)$ $石藥集團(01093.HK)$ $申洲國際(02313.HK)$
Techs slid as the market continued to be watchful of the Sino-US relations:
$阿里巴巴-SW(09988.HK)$ dived 3.2% to $84.1.
$騰訊控股(00700.HK)$ sank 1.9% to $338.4.
$美團-W(03690.HK)$ , $小米集團-W(01810.HK)$ , ...
暫無評論